Lester Lien

PAC-LINK Management Corp. (PAC-LINK) is the venture capital subsidiary of Taiwan-based Yulon Group, a major automotive assembly and textiles industrial group with businesses in nine provinces of China, Taiwan, and the Philippines. Founded in 1998, PAC-LINK invests in dynamic companies in Greater China and North America. The firm is headquartered in Taipei and also has offices in Shanghai and Palo Alto in the US. They manage venture capital funds covering a wide range of industries, working closely with company managers to minimize risks, maximize opportunities, and help build rapidly growing businesses.

DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA.